Zai Lab Limited
- ZLAB
- NASDAQ
- Biotechnology
- Oncology/Autoimmune Drugs
- China Biopharma
$23.19
Today −1.36%Quote Oct 16, 2026, 08:00 PM UTC
−10.15%over the last month
Max drawdown −14.9%From 1-month high −12.3%3 months +13.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.60B
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$53.75
+131.8% from here
Floor
$22.06
4.9% below price
Where the price sits
11 analysts
Analyst range, low to high
$35.00$75.00
- Price $23.19
- Resistance $23.53
- Consensus $53.75
The price is right under resistance. Analysts' average target sits about 132% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ZLABPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $106.3M
- Zejula$32.1M30.2%
- Nuzyra$17.1M16.1%
- Optune$12.2M11.5%
- Qinlock$9.6M9.0%
- Other / not reported$35.3M33.2%
Industry
Biotechnology
Employees
1,784